시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
인공심폐장치 시장 : 성장, 전망, 경쟁 분석(2025-2033년)
Heart Lung Machine Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033
상품코드 : 1665869
리서치사 : Acute Market Reports
발행일 : 2025년 01월
페이지 정보 : 영문 174 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,500 ￦ 6,160,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,500 ￦ 8,899,000
PDF (Multi User License) help
PDF 보고서를 동일 사업장에서 10명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 9,000 ￦ 12,321,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

인공심폐장치는 심폐우회장치라고도 불리며, 심장 수술 시 심장과 폐의 기능을 일시적으로 대신하는 중요한 의료장비입니다. 이 기계가 혈액을 순환시키고 산소를 공급함으로써 외과 의사는 정지된 무혈 심장으로 수술을 할 수 있습니다. 일반적으로 심장 이식, 관상동맥 우회술, 복잡한 판막 수리 및 교체 등의 수술에 사용됩니다. 인공심폐장치는 펌프, 산소공급장치, 필터, 저수지, 튜브 등 다양한 부품으로 구성되어 있어 조작이 용이합니다. 인공심폐장치 시장 규모는 예측 기간 동안 7%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다.

심혈관 질환(CVD)의 전 세계적인 증가는 인공심폐장치 시장의 중요한 촉진요인으로, CVD는 여전히 세계 주요 사망 원인 중 하나이며, 관상동맥 우회술 및 심장판막 수복술과 같은 심장 수술에 대한 수요는 지속적으로 증가하고 있습니다. 이러한 수술 증가는 복잡한 수술 중 순환 및 호흡 지원을 유지하는 데 필수적인 인공 심폐 장치의 사용을 필요로 합니다. 인구 고령화, 고혈압, 당뇨병, 비만과 같은 위험인자 증가와 함께 심장병의 유병률을 더욱 악화시키고 심장 수술의 필요성을 증가시키고 있습니다. 수술 기법의 발전과 이에 따라 심폐우회술에 의존하는 수술의 성공률이 상승하고 있는 것도 시장을 발전시키고 있습니다.

인공심폐장치 시장에서 새로운 기회가 되고 있는 것은 기계의 기능성과 환자의 안전성을 향상시키는 첨단 기술의 통합입니다. 첨단 모니터링 시스템과 산소 공급 장치의 개선 개발로 수술 중 생리적 변수를 보다 정확하게 제어할 수 있어 합병증 위험을 줄일 수 있습니다. 이러한 기술적 개선은 수술의 효율성을 높일 뿐만 아니라 더 복잡한 심장 질환의 치료 가능성을 넓힐 수 있습니다. 기계의 소형화 및 수술 중 자동 조정을 위한 인공지능 탑재와 같은 기술 혁신은 인공 심폐 장치의 적용 범위를 넓혀 더 광범위한 의료 환경에 호소력을 발휘하고 시장 침투를 높일 것으로 예상됩니다.

인공 심폐 장치 시장에 영향을 미치는 주요 요인은 이러한 장치와 관련된 높은 비용입니다. 기술의 복잡성과 승인에 필요한 엄격한 규제 기준으로 인해 인공심폐장치는 특히 고가이며, 자금이 부족한 의료 시스템이나 개발도상국에서는 사용이 제한될 수 있습니다. 또한, 높은 비용은 장비의 유지보수 및 필요한 업그레이드에도 영향을 미치기 때문에 소규모 의료 기관에게는 재정적 부담이 될 수 있으며, 이로 인해 채택률이 낮아질 수 있습니다. 이러한 경제적 장벽은 특히 의료비 지출이 제한된 경제적으로 제약적인 환경에서는 시장 성장을 제한할 수 있습니다.

인공심폐장치 시장에서 중요한 과제는 복잡한 규제 및 컴플라이언스 상황을 극복하는 것입니다. 의료기기, 특히 인공 심폐 장치와 같이 생명을 유지하는 의료기기는 안전성과 유효성을 보장하기 위해 엄격한 규제 당국의 감독을 받으며, FDA나 EMA와 같은 기관으로부터 승인을 받는 과정은 종종 대규모 임상시험과 문서화가 필요하며, 장기적이고 자원 집약적인 과정입니다. 또한, 다양한 국제 표준과 규제를 준수해야 하기 때문에 신기술의 세계 유통과 채택이 복잡해집니다. 이러한 규제 압력은 혁신적인 제품 시장 출시를 지연시키고, 빠른 기술 발전과 채택을 방해할 수 있습니다.

세계의 인공심폐장치 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별/용도별/최종사용자별/지역별 동향, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 서문

제2장 주요 요약

제3장 인공심폐장치 시장 : 경쟁 분석

제4장 인공심폐장치 시장 : 매크로 분석과 시장 역학

제5장 인공심폐장치 시장 : 2023년-2033년

제6장 인공심폐장치 시장 : 제품 유형별, 2023년-2033년

제7장 인공심폐장치 시장 : 용도별, 2023년-2033년

제8장 인공심폐장치 시장 : 최종사용자별, 2023년-2033년

제9장 북미의 인공심폐장치 시장 : 2023년-2033년

제10장 영국 및 EU의 인공심폐장치 시장 : 2023년-2033년

제11장 아시아태평양의 인공심폐장치 시장 : 2023년-2033년

제12장 라틴아메리카의 인공심폐장치 시장 : 2023년-2033년

제13장 중동 및 아프리카의 인공심폐장치 시장 : 2023년-2033년

제14장 기업 개요

LSH
영문 목차

영문목차

A heart-lung machine, also known as a cardiopulmonary bypass machine, is a crucial medical device used during cardiac surgery to temporarily take over the function of the heart and lungs. This machine circulates and oxygenates the blood, allowing surgeons to perform procedures on a still and bloodless heart. It is typically used during surgeries such as heart transplants, coronary artery bypass grafting, and complex valve repair or replacement surgeries. The heart-lung machine consists of various components including pumps, oxygenators, filters, reservoirs, and tubing to facilitate its operation. The heart-lung machine market is projected to grow at a CAGR of 7% over the forecast period.

Increasing Prevalence of Cardiovascular Diseases

The global rise in cardiovascular diseases (CVDs) serves as a significant driver for the heart-lung machine market. As CVDs remain one of the leading causes of death worldwide, the demand for cardiac surgeries, such as coronary artery bypass grafts and heart valve repairs, continues to escalate. This increase in surgical interventions necessitates the use of heart-lung machines, which are critical for maintaining circulatory and respiratory support during complex procedures. The aging population, along with rising risk factors such as hypertension, diabetes, and obesity, further exacerbates the prevalence of heart diseases, thereby increasing the need for cardiac surgeries. The ongoing development in surgical techniques and the subsequent rise in successful outcomes from surgeries that depend on cardiopulmonary bypass technologies also drive the market forward.

Technological Advancements in Machine Functionality

An emerging opportunity within the heart-lung machine market is the integration of advanced technologies that enhance machine functionality and patient safety. The development of sophisticated monitoring systems and improved oxygenators facilitates more precise control over physiological variables during surgery, thereby reducing the risk of complications. These technological improvements not only boost the efficiency of surgical procedures but also extend the potential for treating more complex cardiac conditions. Innovations such as miniaturized machines and the inclusion of artificial intelligence for automated adjustments during surgery are expected to broaden the scope of heart-lung machine applications, appealing to a wider array of healthcare settings and increasing market penetration.

High Cost of Heart-Lung Machines

A primary restraint impacting the heart-lung machine market is the high cost associated with these devices. The complexity of the technology and the stringent regulatory standards required for approval make these machines particularly expensive, which can limit accessibility in underfunded healthcare systems and developing regions. The high cost also extends to maintenance and necessary upgrades of the machine, which may pose financial challenges to smaller medical institutions and result in slower adoption rates. This financial barrier can restrict the market's growth, particularly in economically constrained environments where healthcare spending is limited.

Regulatory and Compliance Hurdles

A significant challenge in the heart-lung machine market is navigating the complex regulatory and compliance landscape. Medical devices, particularly those that are life-sustaining like heart-lung machines, are subject to rigorous regulatory scrutiny to ensure safety and efficacy. The process of obtaining approval from bodies such as the FDA and EMA can be lengthy and resource-intensive, often requiring extensive clinical testing and documentation. Additionally, the need to adhere to varying international standards and regulations complicates the global distribution and adoption of new technologies. These regulatory pressures can delay the introduction of innovative products to the market, impeding rapid technological advancements and adoption.

Market Segmentation by Product Type

In the heart-lung machine market, segmentation by product type includes Systems and Components. The Systems segment commands the highest revenue due to the essential role these complete setups play in cardiac surgeries. Heart-lung systems are comprehensive units equipped with pumps, oxygenators, filters, and various other necessary devices to support cardiac and pulmonary functions during surgery. This segment benefits from continuous innovations aimed at enhancing machine efficiency and patient safety, sustaining its market dominance. On the other hand, the Components segment is projected to experience the highest CAGR. This growth is fueled by the ongoing need for replacement parts and upgrades, which are critical to maintaining the functionality and extending the lifespan of existing systems. Components such as oxygenators, filters, and tubing require regular updates due to wear and technological advancements, driving their demand in the market.

Market Segmentation by Application

The heart-lung machine market is also segmented by application, encompassing Open Heart Surgery, Lung Transplant, Heart Transplant, and Others. Open Heart Surgery holds the highest revenue within this segmentation, as it is the most common application for heart-lung machines. This procedure relies heavily on these machines to maintain circulatory and respiratory support while the heart is temporarily stopped. As cardiovascular diseases increase and surgical techniques advance, the demand for open heart surgeries continues to grow, supporting this segment's revenue dominance. Conversely, the Heart Transplant segment is expected to register the highest CAGR. With improvements in surgical outcomes and an increasing number of transplant centers worldwide, more heart transplants are being performed. This trend is anticipated to drive significant growth in the market for heart-lung machines, as they are crucial for the success of these complex procedures.

Geographic and Competitive Trends in the Heart-Lung Machine Market

Geographically, the heart-lung machine market exhibits significant trends, with North America holding the highest revenue share in 2024. This dominance is attributed to advanced healthcare infrastructure, high healthcare spending, and a substantial rate of cardiovascular procedures in the region. North America's market leadership is further supported by the presence of leading medical device manufacturers and rigorous health regulations that drive the adoption of advanced surgical technologies. However, the Asia-Pacific region is expected to exhibit the highest CAGR from 2025 to 2033. This anticipated growth is driven by increasing healthcare expenditures, rising awareness of cardiovascular diseases, and improvements in healthcare facilities in countries such as China and India. The expansion of healthcare infrastructure and the rising number of trained medical professionals performing cardiac surgeries are expected to significantly boost the demand for heart-lung machines in this region.

In terms of competitive trends, the heart-lung machine market is characterized by a concentration of specialized medical device companies that continually innovate and expand their product portfolios. In 2024, major players focused on technological advancements to enhance the safety, efficiency, and user-friendliness of their machines. These companies also invested in expanding their global footprint through strategic alliances, mergers, and acquisitions to strengthen their market positions and enter new geographical areas. From 2025 to 2033, the key strategies in the market are expected to center on continuous innovation, particularly in integrating digital technologies like real-time monitoring and data analysis into heart-lung machines. This integration aims to improve patient outcomes and streamline surgical workflows. Furthermore, manufacturers are likely to increase their investment in emerging markets where the rising number of cardiac surgeries presents new opportunities for growth. The focus will also be on regulatory compliance and meeting the stringent standards set by global health authorities to ensure market entry and acceptance in diverse healthcare settings.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Heart Lung Machine market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Heart Lung Machine market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Key questions answered in this report

Table of Contents

1. Preface

2. Executive Summary

3. Heart Lung Machine Market: Competitive Analysis

4. Heart Lung Machine Market: Macro Analysis & Market Dynamics

5. Heart Lung Machine Market: By , 2023-2033, USD (Million)

6. Heart Lung Machine Market: By Product Type, 2023-2033, USD (Million)

7. Heart Lung Machine Market: By Application, 2023-2033, USD (Million)

8. Heart Lung Machine Market: By End-user, 2023-2033, USD (Million)

9. North America Heart Lung Machine Market, 2023-2033, USD (Million)

10. UK and European Union Heart Lung Machine Market, 2023-2033, USD (Million)

11. Asia Pacific Heart Lung Machine Market, 2023-2033, USD (Million)

12. Latin America Heart Lung Machine Market, 2023-2033, USD (Million)

13. Middle East and Africa Heart Lung Machine Market, 2023-2033, USD (Million)

14. Company Profile

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기